NCT06822959View on ClinicalTrials.gov

Pharmacogenetics, Therapeutic Drug Monitoring (TDM) and Active Pharmacovigilance as Innovative Tools Aimed at the Optimisation/ Appropriateness of Drug Therapy

RecruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

June 10, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Adverse Drug Reaction (ADR)
Interventions
OTHER

Pharmacogenetics, TDM and MedReview

Patients will undergo pharmacogenetics, TDM and MedReview analyses according to the study protocol

Trial Locations (2)

33081

RECRUITING

Centro di Riferimento Oncologico di Aviano (CRO), Aviano

34137

RECRUITING

IRCCS materno infantile Burlo Garofolo di Trieste, Trieste

All Listed Sponsors
collaborator

Centro di Riferimento Oncologico - Aviano

OTHER

collaborator

IRCCS Burlo Garofolo

OTHER

lead

Direzione centrale salute, politiche sociali e disabilità

OTHER